Amy McKee's most recent trade in Biocryst Pharmaceuticals Inc. was a trade of 676 Common Stock done at an average price of $8.3 . Disclosure was reported to the exchange on Aug. 29, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 8.31 per share. | 29 Aug 2025 | 676 | 41,007 (0%) | 0% | 8.3 | 5,618 | Common Stock |
| Biocryst Pharmaceuticals Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 27,181 | 27,181 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc | Amy E. McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 12,500 | 40,331 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc | Amy McKee | Director | Sale of securities on an exchange or to another person at price $ 6.32 per share. | 24 Jun 2024 | 8,600 | 27,831 (0%) | 0% | 6.3 | 54,352 | Common Stock |
| Biocryst Pharmaceuticals Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 49,933 | 49,933 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 6,820 | 36,431 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 39,072 | 39,072 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 16,745 | 29,611 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 30,022 | 30,022 | - | - | Automatic Stock Option Grant | |
| Biocryst Pharmaceuticals Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 12,866 | 12,866 (0%) | 0% | 0 | Common Stock | |
| Biocryst Pharmaceuticals Inc | Amy McKee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Sep 2021 | 53,333 | 53,333 | - | - | Non-Qualified Stock Option |